Werewolf Therapeutics, Inc. cotiza a 0.98 USD y tiene una capitalización bursátil de $48M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for ad…
| Periodo | 2026-10 | 2026-07 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $0.14 | $-0.28 | $-0.17 |
| Estimado | $-0.32 | $-0.32 | $-0.29 | $-0.35 |
| Sorpresa | — | +143.8% | +3.4% | +51.4% |
| Métrica | HOWL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -245.2% | -40.4% | -204.8% |
| ROA | -87.6% | -32.0% | -55.6% |
| Current Ratio | 1.62 | 2.84 | -1.22 |
| Debt / Equity | 1.29 | 0.28 | +1.01 |